↓ Skip to main content

Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma

Overview of attention for article published in Frontiers in oncology, July 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
8 Mendeley